marwankefah/TriALS
TriALS: Triphasic-Aided Liver Lesion Segmentation Benchmark in Non-Contrast CT Same patient across all four CT phases (non-contrast, arterial, portal venous, delayed). Top row: raw images. Bottom row: lesion annotations. Many lesions are occult on non-contrast CT and only become conspicuous after contrast administration — this is the core diagnostic challenge TriALS targets. TriALS is the first multi-centre benchmark for liver lesion segmentation in non-contrast CT (NCCT)… See the full description on the dataset page: https://huggingface.co/datasets/marwankefah/TriALS.
| Author / organization | marwankefah |
|---|---|
| License (as declared) | cc-by-nc-4.0 |
| Downloads | 340 (as reported by Hugging Face) |
| Likes | 3 |
| Created | 12 April 2026 |
| Last updated at source | 10 October 2026 |
Popularity, last 3 days
340 now (-7 since 2026-10-16). Counts as reported by the source, snapshotted daily by Silytics.
Connected in the knowledge graph
Related papers
More from marwankefah
Silytics shows public metadata from Hugging Face and links to the original. Information may be incomplete or out of date. Last refreshed 18 October 2026. Licenses and terms of the original apply to the work itself. Not financial, legal or professional advice.